SomaGen® Meshed is an acellular human reticular dermal allograft with a unique meshed design that provides a scaffold to support the treatment of a variety of complex wounds. The versatile meshing ratio allows for expansion to provide coverage for a wide range of wound sizes and needs. It is processed from a deep cut in the dermal layer of skin, and from which the epidermal layer has been physically removed. The process utilized preserves the extracellular matrix of the dermis. The resulting allograft serves as a framework to support cellular repopulation and vascularization at the surgical site.
SomaGen® Meshed is processed to remove cells while maintaining the integrity of the matrix with the intent to address the issues of the specific and nonspecific inflammatory responses. SomaGen® Meshed is used as a wound care scaffold for the replacement of damaged or inadequate integumental tissue such as diabetic foot ulcers, venous leg ulcers, pressure ulcers, or for other homologous use.
Conditions that could potentially inhibit integration of SomaGen® Meshed include, but are not limited to:local or systemic infection, inflammatory response of non-infectious cause, uncontrolled diabetes, pregnancy, low vascularity of the surrounding tissue, mechanical trauma, poor nutrition or poor general medical condition, dehiscence and/or necrosis due to poor revascularization, inability to cooperate with and/or comprehend post-operative instructions, and infected or nonvascular surgical sites.
Do not sterilize. Do not freeze. No known sensitizing agents are present in this tissue. SomaGen® Meshed is packaged in an ethanol solution and must be rinsed in a sterile solution prior to implantation. .Care should be taken when using SomaGen® Meshed in conjunction with electrical equipment.
NOTE: No antibiotics were used during the processing of this tissue.Extensive medical screening procedures have been used in the selection of all tissue donors for MTF (please see Donor Screening and Testing). Transmission of infectious diseases may occur despite of careful donor selection and Laboratory testing, including serology and nucleic acid testing (NAT).
Possible adverse effects of using ADM include but are not limited to: local or systemic infection, dehiscence and/or necrosis due to poor revascularization and a specific or nonspecific immune response to the graft.
Store at ambient temperature. Do not refrigerate or freeze.
|Assigned HCPCS code|
|Shelf life greater than 2 years|
|Shelf life limited|
|Indicated for acute wounds||●|
|Indicated for chronic wounds|
|Indicated for diabetic ulcers||●|
|Indicated for pressure ulcers||●|
|Indicated for surgical wounds||●|
|Indicated for third-degree burns||●|
|Indicated for venous ulcers||●|
|Contact manufacturer for usage guidelines|
|Educational Material Available||●|
|Free Samples/Trials Available||●|
|Published Clinical Article Available|
Moderate/Highly Exudating Wounds
Can be applied directly to wound and fixated using sutures or staples as needed.
MTF Biologics Wound Care is a division of MTF Biologics, a leading non-profit tissue bank. The Wound Care division is dedicated to developing highly advanced, safe, clinically-based and cost-effective wound care solutions that work in concert with the body's natural healing process.